216 studies found for:    "SARS"
Show Display Options
Rank Status Study
1 Completed Collection of Convalescent SARS Plasma by Apheresis
Conditions: Severe Acute Respiratory Syndrome;   SARS
Intervention:
2 Completed Investigating Severe Acute Respiratory Syndrome (SARS)
Condition: SARS Virus
Intervention:
3 Withdrawn SARS Coronavirus Vaccine (SARS-CoV)
Condition: Coronavirus (SARS-CoV)
Interventions: Drug: Aluminum hydroxide;   Drug: Placebo;   Biological: SARS-CoV
4 Withdrawn Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS)
Condition: Severe Acute Respiratory Syndrome
Intervention:
5 Not yet recruiting A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
Condition: Severe Acute Respiratory Syndrome
Intervention: Drug: Lopinavir / Ritonavir plus Ribavirin
6 Withdrawn Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study
Condition: SARS
Interventions: Drug: Aluminum hydroxide adjuvant (Alhydrogel®);   Other: Phosphate buffered saline Placebo;   Biological: Recombinant S protein SARS vaccine
7 Withdrawn SARS Survivor Evaluations
Condition: Coronavirus (SARS-CoV)
Intervention:
8 Completed Dynamic Profiles of Cytokine/Chemokine in Severe Acute Respiratory Syndrome
Condition: SARS
Intervention:
9 Completed Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers
Condition: Severe Acute Respiratory Syndrome
Intervention: Drug: Alferon LDO
10 Completed A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis
Conditions: Rhinitis, Allergic, Seasonal;   Seasonal Allergic Rhinitis;   SAR
Intervention: Drug: GSK256066
11 Completed Contamination During Removal of Two Different Personal Protective Systems
Condition: Severe Acute Respiratory Syndrome
Intervention: Procedure: Powered Air purifying respirator
12 Withdrawn The Interaction Between Severe Acute Respiratory Distress Syndrome Viral Proteins and Monocytes
Condition: Severe Acute Respiratory Syndrome
Intervention: Procedure: blood sampling
13 Completed Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)
Condition: Healthy
Interventions: Procedure: Blood Test;   Procedure: Urine Test;   Procedure: Physical Exam;   Drug: Vaccine;   Drug: VRC-SRSDNA015-00-VP
14 Recruiting Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Pimasertib once daily;   Drug: Pimasertib placebo;   Drug: SAR245409  placebo;   Drug: SAR245409;   Drug: Pimasertib twice daily
15 Completed Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)
Condition: Rhinitis, Allergic, Seasonal
Interventions: Drug: Ciclesonide HFA;   Drug: Placebo
16 Completed Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies
Condition: Seasonal Allergic Rhinitis (SAR)
Interventions: Drug: BDP nasal aerosol - 80 microgram dose once daily;   Drug: BDP nasal aerosol - 160 microgram dose once daily;   Drug: Placebo Nasal Aerosol
17 Completed Clinical Study of SARS in Children
Condition: Epidemiology
Intervention:
18 Terminated SAR3419 in Acute Lymphoblastic Leukemia
Condition: Acute Lymphocytic Leukaemia
Intervention: Drug: SAR3419
19 Completed SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer Stage IV
Interventions: Drug: Iniparib;   Drug: gemcitabine;   Drug: cisplatin
20 Active, not recruiting Phase 1 SAR650984 Combination With Lenalidomide
Condition: Multiple Myeloma
Interventions: Drug: SAR650984;   Drug: Lenalidomide

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years